Department of Biomedical Sciences, Section of Neuroscience, University of Cagliari, Cagliari, Italy.
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Neurotoxicology. 2021 Mar;83:1-13. doi: 10.1016/j.neuro.2020.12.005. Epub 2020 Dec 15.
Clinical and preclinical evidence indicates that prenatal exposure to glucocorticoids may induce detrimental effects in the offspring, including reduction in fetal growth and alterations in the CNS. On this basis, the present study investigated whether in utero exposure to high levels of glucocorticoids is a risk factor that may lead to an exacerbation of the central noxious effects induced by psychoactive drugs consumed later in life. To this end, pregnant C57BL6/J dams were treated with dexamethasone (DEX, 0.05 mg/kg per day) from gestational day 14 until delivery. Thereafter, the male offspring were evaluated to ascertain the magnitude of dopaminergic damage, astrogliosis and microgliosis elicited in the nigrostriatal tract by the amphetamine-related drug 3,4--methylenedioxymethamphetamine (MDMA, 4 × 20 mg/kg, 2 h apart, sacrificed 48 h later) administered at either adolescence or adulthood. Immunohistochemistry was performed in the substantia nigra pars compacta (SNc) and striatum, to evaluate dopaminergic degeneration by measuring tyrosine hydroxylase (TH), as well as astrogliosis and microgliosis by measuring glial fibrillary acidic protein (GFAP) and ionized calcium-binding adapter molecule 1 (IBA-1), respectively. Moreover, immunohistochemistry was used to ascertain the co-localization of IBA-1 with either the pro-inflammatory interleukin (IL) IL-1β or the anti-inflammatory IL IL-10, in order to determine the microglial phenotype. In utero administration of DEX induced dopaminergic damage by decreasing the density of TH-positive fibers in the striatum, although only in adult mice. MDMA administration induced dopaminergic damage and glia activation in the nigrostriatal tract of adolescent and adult mice. Mice exposed to DEX in utero and treated with MDMA later in life showed a more pronounced loss of dopaminergic neurons (adolescent mice) and astrogliosis (adolescent and adult mice) in the SNc, compared with control mice. These results suggest that prenatal exposure to glucocorticoids may induce an age-dependent and persistent increase in the susceptibility to central toxicity of amphetamine-related drugs used later in life.
临床和临床前证据表明,产前暴露于糖皮质激素可能会对后代产生有害影响,包括胎儿生长减少和中枢神经系统改变。基于此,本研究调查了宫内暴露于高水平糖皮质激素是否是一个风险因素,可能导致生命后期使用的精神活性药物引起的中枢毒性作用加剧。为此,从妊娠第 14 天到分娩,C57BL6/J 孕鼠每天接受地塞米松(DEX,0.05mg/kg)治疗。此后,评估雄性后代,以确定在青春期或成年期给予安非他命相关药物 3,4-亚甲二氧基甲基苯丙胺(MDMA,4×20mg/kg,间隔 2 小时,48 小时后处死)后,在黑质纹状体束中引起的多巴胺能损伤、星形胶质细胞增生和小胶质细胞增生的程度。在黑质致密部(SNc)和纹状体中进行免疫组织化学染色,通过测量酪氨酸羟化酶(TH)来评估多巴胺能变性,以及通过测量神经胶质纤维酸性蛋白(GFAP)和离子钙结合衔接蛋白 1(IBA-1)来评估星形胶质细胞增生和小胶质细胞增生。此外,免疫组织化学用于确定 IBA-1 与促炎白细胞介素(IL)IL-1β或抗炎白细胞介素(IL)IL-10 的共定位,以确定小胶质细胞表型。宫内给予 DEX 通过减少纹状体中 TH 阳性纤维的密度诱导多巴胺能损伤,尽管仅在成年小鼠中。MDMA 给药在青春期和成年期小鼠的黑质纹状体束中诱导多巴胺能损伤和神经胶质激活。与对照小鼠相比,在生命后期暴露于 DEX 的宫内和用 MDMA 治疗的小鼠在 SNc 中显示出更明显的多巴胺能神经元丧失(青春期小鼠)和星形胶质细胞增生(青春期和成年期小鼠)。这些结果表明,产前暴露于糖皮质激素可能会导致对生命后期使用的安非他命相关药物的中枢毒性的易感性产生年龄依赖性和持续增加。